반응식
Cl.Cl.[N:3]1([C@H:8]2[CH2:13][CH2:12][CH2:11][CH2:10][C@H:9]2[NH2:14])[CH2:7][CH2:6][CH2:5][CH2:4]1.[CH2:15]([C:17]1[CH:25]=[C:24]([C:26]([F:29])([F:28])[F:27])[CH:23]=[CH:22][C:18]=1[C:19](O)=[O:20])[CH3:16]>>[CH2:15]([C:17]1[CH:25]=[C:24]([C:26]([F:27])([F:28])[F:29])[CH:23]=[CH:22][C:18]=1[C:19]([NH:14][C@@H:9]1[CH2:10][CH2:11][CH2:12][CH2:13][C@@H:8]1[N:3]1[CH2:4][CH2:5][CH2:6][CH2:7]1)=[O:20])[CH3:16]참가 물질
3
실험 절차
The title compound, white solid, MS: m/e=369.2 [(M+H)+], was prepared in accordance with the general method of example 5 from cis-2-pyrrolidin-1-yl-cyclohexylamine dihydrochloride (intermediate F) and 2-ethyl-4-(trifluoromethyl)-benzoic acid (CAS 854531-63-8).
출처 및 근거
- ORD 기록
- ord-5c7ccd3e3054465bb1a7609cd2c1abdb
- 출처 데이터셋
- uspto-grants-2011_12
- 특허 번호
- US08080541B2
연결된 노트
불러오는 중…